FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc., representing a regulatory update to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

SUPPL AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)